Piramal Pharma Sees Surge in Open Interest Amid Increased Market Activity
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 8,275 contracts, alongside a trading volume of 10,012 contracts. The stock has outperformed its sector and achieved a recent intraday high, although investor participation has declined. The company maintains a strong market capitalization within the large-cap pharmaceuticals sector.
Piramal Pharma Ltd (PPLPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 8,275 contracts, up from the previous 6,773, marking a change of 1,502 contracts or a 22.18% increase. This surge coincides with a trading volume of 10,012 contracts, indicating robust market engagement.In terms of price performance, Piramal Pharma has outperformed its sector by 2.1%, with the stock gaining 3.19% over the last two days. Today, it reached an intraday high of Rs 208.45, reflecting a 3.72% increase. The stock's current price is above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day averages.
Despite this positive momentum, there has been a noted decline in investor participation, with delivery volume dropping by 22.69% compared to the 5-day average. The stock maintains sufficient liquidity for trades, with a market capitalization of Rs 27,419.73 crore, positioning it firmly within the large-cap segment of the Pharmaceuticals and Biotechnology industry. Overall, the notable increase in open interest highlights a dynamic trading environment for Piramal Pharma.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
